leftspacer middlespacer rightspacer
Media Menu
Featured Material


MAPS BULLETIN
MAPS Bulletin Winter 2013: 2013 Annual Report
 
Media > Recent and Archival
December 13, 2013

Social Anxiety in Autistic Adults: DEA Inspects Study Pharmacy for Schedule I License

On December 13, 2013, the U.S. Drug Enforcement Administration inspected the pharmacy where the MDMA will be stored for our upcoming study of MDMA-assisted therapy for social anxiety in autistic adults. This inspection is required before the DEA will grant the pharmacy a Schedule I license. Principal Investigator Charles Grob, M.D., who is leading the study along with Alicia Danforth, Ph.D., applied for his Schedule I license on October 9 and has already received it. Goals for this study include (1) gathering evidence for the safety and effectiveness of MDMA-assisted therapy for autistic adults diagnosed with social anxiety, (2) determining if additional studies in this area are warranted, and (3) initiating a new program of research into a possible beneficial use of MDMA building on collected case accounts.



Back to MAPS in the Media

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.